How Technological Advancements are Shaping the US Cell Viability Assays Market
The US cell viability assays market is witnessing unprecedented growth, fueled by an increasing emphasis on drug development and technological innovations. According to recent projections, the market is set to surge from a revenue of approximately USD 625.84 million in 2024 to a staggering USD 1,535.6 million by 2035. With a compound annual growth rate (CAGR) of 8.5%, the landscape is...
0 Comments 0 Shares 198 Views 0 Reviews